We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS, Other Drugmakers Sign Drug Price Negotiation Agreements With CMS
BMS, Other Drugmakers Sign Drug Price Negotiation Agreements With CMS
Bristol Myers Squibb (BMS) has struck an agreement with CMS to negotiate the price of its blood thinner medication Eliquis (apixaban) ahead of the Oct. 1 deadline, the drugmaker confirmed to FDAnews Wednesday.